1093.HK - CSPC Pharmaceutical Group Limited

HKSE - HKSE Prezzo differito. Valuta in HKD.

CSPC Pharmaceutical Group Limited

No. 226 Huanghe Street
Shijiazhuang 050035
China
86 311 8703 7015
http://www.cspc.com.hk

SettoreHealthcare
SettoreDrug Manufacturers—General
Impiegati a tempo pieno17.300

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Dongchen CaiExec. Chairman & CEO13,8MN/D1954
Mr. Cuilong ZhangVice-Chairman, Rotating CEO & Pres of Oncology Drug Bus. Division4,33MN/D1969
Mr. Kin Man ChakExec. Director5,27MN/D1966
Mr. Weidong PanExec. Director4,39MN/D1970
Mr. Huaiyu WangExec. Director4,21MN/D1963
Gli importi risalgono al giorno 31 dicembre 2018 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in HKD.

Descrizione

CSPC Pharmaceutical Group Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China, other Asian regions, the Americas, Europe, and internationally. It operates through Finished Drugs, Vitamin C, Antibiotics, and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Xuanning for hypertension; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; Ailineng for nerve glioma and brain metastases, and adjuvant treatment of malignant pleural and peritoneal effusion; Nuolining for chronic myelocytic and acute lymphoblastic leukemia; and Keaili for breast cancer. It also offers generic drugs, including Ouyi for anti-inflammatory, Gubang to treat osteoporosis, and Weihong for various infections, as well as Guoweikang, a vitamin C supplement tablets; traditional Chinese medicine; and antibiotics comprising Amoxicillin and Ampicillin capsules, Ceftriaxone and Cefazolin sodium injections, and Meropenum injections. In addition, the company provides antibiotics, vitamin C, and caffeine APIs; functional food and glucose products; and researches and develops various products with focus on the therapeutic areas of oncology, autoimmunity, psychiatry and neurology, digestion and metabolism, cardio-cerebrovascular system, and anti-infection. Further, it offers storage, sourcing, and distribution services; and healthcare services, as well as sells pharmaceutical equipment. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was founded in 1997 and is headquartered in Shijiazhuang, the People's Republic of China.

Governance aziendale

L'ISS Governance QualityScore di CSPC Pharmaceutical Group Limited al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.
Usando Yahoo accetti che Yahoo e i suoi partners utilizzino cookies per fini di personalizzazione e altre finalità